Last updated on June 2019

Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study


Brief description of study

The AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007. This study is designed to further evaluate the safety and effectiveness in subjects implanted with the AMPLATZER Muscular VSD Occluder.

Clinical Study Identifier: NCT00647387

Find a site near you

Start Over

University of Maryland

Baltimore, MD United States
6.25miles
  Connect »